NOTES
TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
FOR THE THREE MONTHS ENDED MARCH 31, 2023 AND 2022
NOTE
1 – ORGANIZATION AND DESCRIPTION OF THE BUSINESS
The
Crypto Company was incorporated in the State of Nevada on March 9, 2017. The Company is engaged in the business of providing consulting,
training, and educational and related services for distributed ledger technologies (“blockchain”), for corporate and individual
clients, enterprises for general blockchain education, as well as for the building of technological infrastructure and enterprise blockchain
technology solutions. In recent periods the Company has generated revenues and incurred expenses primarily through these consulting and
related operations.
Unless
expressly indicated or the context requires otherwise, the terms “Crypto,” the “Company,” “we,” “us,”
and “our” in these consolidated financial statements refer to The Crypto Company and, where appropriate, its wholly-owned
subsidiary Blockchain Training Alliance, Inc. (“BTA”) and an inactive subsidiary Coin Tracking, LLC (“CoinTracking”).
The
Company entered into a Stock Purchase Agreement (the “SPA”) effective as of March 24, 2021 with BTA and its stockholders.
On April 8, 2021, the Company completed the acquisition of all of the issued and outstanding stock of BTA and BTA became a wholly-owned
subsidiary of the Company. As a result of this acquisition, the operations of BTA became consolidated with Company operations on April
8, 2021.
BTA
is a blockchain training company and service provider that provides training and educational courses focused on blockchain technology
and education as to the general understanding of blockchain to corporate and individual clients.
The
Company’s accounting year-end is December 31.
COVID-19
On
March 11, 2020, the World Health Organization declared the Covid-19 outbreak to be a global pandemic. In addition to the devastating
effects on human life, the pandemic has, in general, had a negative ripple effect on the global economy, leading to disruptions and volatility
in the global financial markets, and has contributed to inflation, supply chain constraints, labor shortages and other adverse economic
effects. Most U.S. states and many countries have, at times, issued various policies intended to stop or slow the further spread of the
disease.
Covid-19
and the U.S.’s response to the pandemic has caused economic volatility since the pandemic’s outbreak. There are no recent
comparable events that provide guidance as to the effect the Covid-19 pandemic may have, and, as a result, the ultimate effect of the
pandemic is highly uncertain and subject to change. We do not yet know the full extent of the effects on the economy, the markets we
serve, our business, or our operations.
NOTE
2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Going Concern
The
Company’s consolidated financial statements are prepared using the accrual method of accounting in accordance with United
States (“U.S.”) generally accepted accounting principles (“GAAP”) and have been prepared on a going concern
basis, which contemplates the realization of assets and the settlement of liabilities in the normal course of business. The Company
has incurred significant losses and experienced negative cash flows since inception. As of March 31, 2023, the Company had cash of
$16,677. In addition, the Company’s net
loss was $2,771,331 for
the three months ended March 31,2023 and the Company’s had a working capital deficit of $4,804,595.
As of March 31, 2023, the accumulated deficit amounted to $42,302,767.
As a result of the Company’s history of losses and financial condition, there is substantial doubt about the ability of the
Company to continue as a going concern.
The
ability to continue as a going concern is dependent upon the Company generating profitable operations in the future and/or obtaining
the necessary financing to meet its obligations and repay its liabilities arising from normal business operations when they come due.
Management is evaluating different strategies to obtain financing to fund the Company’s expenses and achieve a level of revenue
adequate to support the Company’s current cost structure. Financing strategies may include, but are not limited to, private placements
of capital stock, debt borrowings, partnerships and/or collaborations. There can be no assurance that any of these future-funding efforts
will be successful. The consolidated financial statements do not include any adjustments relating to the recoverability and classification
of recorded asset amounts or the amounts and classification of liabilities that might result from the outcome of this uncertainty.
Management’s
Representation of Interim Financial Statements
The
accompanying unaudited consolidated financial statements have been prepared by the Company without audit pursuant to the rules and regulations
of the Securities and Exchange Commission (“SEC”). Certain information and disclosures normally included in financial statements
prepared in accordance with accounting principles generally accepted in the United States (“GAAP”) have been condensed or
omitted as allowed by such rules and regulations, and management believes that the disclosures are adequate to make the information presented
not misleading. These consolidated financial statements include all of the adjustments, which in the opinion of management are necessary
to a fair presentation of financial position and results of operations. All such adjustments are of a normal and recurring nature. Interim
results are not necessarily indicative of results for a full year. These consolidated financial statements should be read in conjunction
with the audited consolidated financial statements as of December 31, 2022.
The
Company prepares its consolidated financial statements based upon the accrual method of accounting, recognizing income when earned and
expenses when incurred.
Basis
of Presentation and Principles of Consolidation
Use
of estimates
The
preparation of these consolidated financial statements in conformity with GAAP requires management to make estimates and judgments that
affect the reported amounts of assets, liabilities, revenues, and expenses and the related disclosure of contingent assets and liabilities.
The Company bases its estimates on historical experience and on various other assumptions that it believes to be reasonable under the
circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are
not readily apparent from other sources. The Company’s significant estimates and assumptions include but are not limited to the
valuation allowances of deferred taxes, and share-based compensation expenses. Actual results may differ from these estimates. In addition,
any change in these estimates or their related assumptions could have an adverse effect on the Company’s operating results.
Cash
and cash equivalents
The
Company defines its cash and cash equivalents to include only cash on hand and certain highly liquid investments with original maturities
of ninety days or less. The Company maintains its cash and cash equivalents at financial institutions, the balances of which may, at
times, exceed federally insured limits. Management believes that the risk of loss due to the concentration is minimal.
Investments
in cryptocurrency
Investments
were comprised of several cryptocurrencies the Company owned, of which a majority was Bitcoin, that were actively traded on exchanges.
During 2018, the Company sold most of its investments and during 2019 wrote-off the remainder of all those investments because there
was no method to obtain liquidity for those investments. The Company recorded this recovery as other income in its financial statements.
As previously disclosed, the Company has ceased operations of its former cryptocurrency investment segment, and the Company liquidates
newly issued/accessible assets from old investments as promptly as practicable for the sole purpose of winding down the Company’s
legacy cryptocurrency investment segment.
The
Company records its investments as indefinite-lived intangible assets at cost less impairment and are reported as long-term assets in
the consolidated balance sheets. An intangible asset with an indefinite useful life is not amortized but assessed for impairment annually,
or more frequently, when events or changes in circumstances occur indicating that it is more likely than not that the indefinite-lived
asset is impaired. Impairment exists when the carrying amount exceeds its fair value. In testing for impairment, the Company has the
option to first perform a qualitative assessment to determine whether it is more likely than not that an impairment exists. If it is
determined that it is not more likely than not that an impairment exists, a quantitative impairment test is not necessary. If the Company
concludes otherwise, it is required to perform a quantitative impairment test. To the extent an impairment loss is recognized, the loss
establishes the new cost basis of the asset. Subsequent reversal of impairment losses is not permitted. The primary exchanges and principal
markets the Company utilized for its trading were Kraken, Bittrex, Poloniex, and Bitstamp.
As
of March 31, 2023, the Company had written off the value of its investments in cryptocurrency.
Investments
non-cryptocurrency
The
Company previously invested in simple agreement for future tokens (“SAFT”) and a simple agreement for future equity
(“SAFE”) agreements. The SAFT agreements provide for the issuance of tokens in anticipation of a future token generation
event, with the number of tokens predetermined based on the price established in each respective agreement. The SAFE investment
included provisions that provide for either equity or tokens or both. As of March 31, 2023, and December 31, 2022 the Company had
written-off its investments in non- cryptocurrency.
Business
combination
The
purchase price of an acquired company is allocated between tangible and intangible assets acquired and liabilities assumed from the acquired
business based on their estimated fair values with the residual of the purchase price recorded as goodwill. The results of operations
of acquired businesses are included in our operating results from the dates of acquisition.
Income
taxes
Deferred
tax assets and liabilities are recognized for expected future consequences of events that have been included in the financial statements
or tax returns. Under the asset and liability method, deferred income tax assets and liabilities are determined based on the differences
between the financial reporting and tax bases of assets and liabilities and are measured using the currently enacted tax rates and laws.
A valuation allowance is provided for the amount of deferred tax assets that, based on available evidence, are not expected to be realized.
The provision for income taxes represents the tax payable for the period and the change during the period in deferred tax assets and
liabilities.
When
tax returns are filed, it is highly certain that some positions taken would be sustained upon examination by the taxing authorities,
while others are subject to uncertainty about the merits of the position taken or the amount of the position that would be ultimately
sustained. The benefit of a tax position is recognized in the financial statements in the period during which, based on all available
evidence, management believes it is more likely than not that the position will be sustained upon examination, including the resolution
of appeals or litigation processes, if any. Tax positions taken are not offset or aggregated with other positions. Tax positions that
meet the more-likely-than-not recognition threshold are measured as the largest amount of tax benefit that is more than 50 percent likely
of being realized upon settlement with the applicable taxing authority. The portion of the benefits associated with tax positions taken
that exceed the amount measured as described above is reflected as a liability for unrecognized tax benefits along with any associated
interest and penalties that would be payable to the taxing authorities upon examination.
As
of March 31, 2023, we are subject to federal taxation in the U.S., as well as state taxes. The Company has not been audited by the
U.S. Internal Revenue Service.
Fair
value measurements
The
Company recognizes and discloses the fair value of its assets and liabilities using a hierarchy that prioritizes the inputs to valuation
techniques used to measure fair value. The hierarchy gives the highest priority to valuations based upon unadjusted quoted prices in
active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to valuations based upon unobservable
inputs that are significant to the valuation (Level 3 measurements). Each level of input has different levels of subjectivity and the
difficulty involved in determining fair value.
Level
1 Inputs are unadjusted, quoted prices for identical assets or liabilities in active markets at the measurable date.
Level
2 Inputs, other than quoted prices included in Level 1, which are observable for the asset or liability through corroboration with market
data at the measurement date. Level 3 Unobservable inputs that reflect management’s best estimate of what participants would use
in pricing the asset or liability at the measurement date.
The
carrying amounts of the Company’s financial assets and liabilities, including cash, accounts payable and accrued expenses approximate
fair value because of the short maturity of these instruments.
Revenue
recognition
The
Company recognizes revenue under ASC 606, Revenue from Contracts with Customers (“ASC 606”). The core principle of the new
revenue standard is that a company should recognize revenue to depict the transfer of promised goods or services to customers in an amount
that reflects the consideration to which the company expects to be entitled in exchange for those goods or services. The following five
steps are applied to achieve that core principle:
|
● |
Step
1: Identify the contract with the customer |
|
● |
Step
2: Identify the performance obligations in the contract |
|
● |
Step
3: Determine the transaction price |
|
● |
Step
4: Allocate the transaction price to the performance obligations in the contract |
|
● |
Step
5: Recognize revenue when the Company satisfies a performance obligation |
In
order to identify the performance obligations in a contract with a customer, a company must assess the promised goods or services in
the contract and identify each promised good or service that is distinct. A performance obligation meets ASC 606’s definition of
a “distinct” good or service (or bundle of goods or services) if both of the following criteria are met: The customer can
benefit from the good or service either on its own or together with other resources that are readily available to the customer (i.e.,
the good or service is capable of being distinct), and the entity’s promise to transfer the good or service to the customer is
separately identifiable from other promises in the contract (i.e., the promise to transfer the good or service is distinct within the
context of the contract).
If
a good or service is not distinct, the good or service is combined with other promised goods or services until a bundle of goods or services
is identified that is distinct.
The
transaction price is the amount of consideration to which an entity expects to be entitled in exchange for transferring promised goods
or services to a customer. The consideration promised in a contract with a customer may include fixed amounts, variable amounts, or both.
When determining the transaction price, an entity must consider the effects of all of the following:
Variable
consideration is included in the transaction price only to the extent that it is probable that a significant reversal in the amount of
cumulative revenue recognized will not occur when the uncertainty associated with the variable consideration is subsequently resolved.
The transaction price is allocated to each performance obligation on a relative standalone selling price basis. The transaction price
allocated to each performance obligation is recognized when that performance obligation is satisfied, at a point in time or over time
as appropriate.
The
Company adopted ASC 606 as of January 1, 2018, using the modified retrospective transition method for contracts as of the date of initial
application. There was no cumulative impact on the Company’s retained earnings.
During
the period ended March 31, 2023, the Company’s main source of revenue was consulting and education services to numerous
customers provided by and through BTA. The Company has determined that revenue should be recognized over time, as the service is
provided. The Company considered the criteria in ASC 606 in reaching this determination, specifically:
|
● |
The
customer receives and consumes the benefit provided by the Company’s performance as the Company performs. |
|
● |
The
Company’s performance enhances an asset controlled by the customer. |
|
● |
The
Company’s performance does not create an asset with alternative use, and the Company has an enforceable right to payment for
performance completed to date. |
The
consulting arrangement meets more than one of the criteria above.
Revenues
from Mining at Hosted Locations
The
Company has their mining equipment a hosting facility managed by a third party (“Host”). The equipment generating the
hosting revenue is owned by the Company. Through the period ended March 31, 2023 the Host accepted the mining proceeds daily from a
mining pool into a cold wallet address in the Host’s name. The Host sends the Company its portion daily, as the Host receives
such proceeds. Hosting revenues consist of amounts received in U.S. dollars for a percentage of cryptocurrency generated by the
Host.
Share-based
compensation
In
accordance with ASC No. 718, Compensation-Stock Compensation, the Company measures the compensation costs of share-based compensation
arrangements based on the grant date fair value of granted instruments and recognizes the costs in financial statements over the period
during which employees are required to provide services. Share-based compensation arrangements include stock options.
On
January 1, 2019, the Company adopted ASC No. 2018-07, Improvements to Nonemployee Share-Based Payment Accounting, which simplifies
the accounting for share-based payments to nonemployees by aligning it with the accounting for share-based payments to employees, with
certain exceptions. Previously, share-based payments to nonemployees was accounted for in accordance with ASC No. 505, Equity-Based Payments
to Non-Employees, which required compensation cost to be remeasured at fair value at each reporting period when the award vests. As a
result, stock option-based payments to non- employees resulted in significant volatility in compensation expense in prior years.
The
Company accounts for its share-based compensation using the Black-Scholes model to estimate the fair value of stock option awards. Using
this model, fair value is calculated based on assumptions with respect to the (i) expected volatility of the Company’s common stock
price, (ii) expected life of the award, which for options is the time over which employees and non- employees are expected to hold their
options prior to exercise, and (iii) risk-free interest rate.
Net
loss per common share
The
Company reports earnings per share (“EPS”) with a dual presentation of basic EPS and diluted EPS. Basic EPS is computed
as net income divided by the weighted average of common shares for the period. Diluted EPS reflects the potential dilution that
could occur from common shares issued through stock options, or warrants. For the three-month periods ended March 31, 2023,
and 2022, the Company had no potentially dilutive common stock equivalents. Therefore, the basic EPS and diluted EPS are the
same.
NOTE
3 - RECENT ACCOUNTING PRONOUNCEMENTS
The
Company has implemented all new accounting pronouncements that are in effect and that may impact its financial statements and does not
believe that there are any other new pronouncements that have been issued that might have a material impact on its financial position
or results of operations.
NOTE
4 -GOODWILL AND INTANGIBLE ASSETS
The
Company entered into a Stock Purchase Agreement (the “SPA”) effective as of March 24, 2021 with BTA and its stockholders.
On April 8, 2021, the Company completed the acquisition of all of the issued and outstanding stock of BTA and BTA became a wholly owned
subsidiary of the Company. At the closing the Company delivered to the sellers a total of $600,000 in cash, promissory notes in the total
principal amount of $150,000 bearing 1% interest per annum, and an aggregate of 201,439 shares of Company common stock valued at $604,317
in accordance with the terms of the SPA. Additionally, the Company acquired $4,860 in cash at BTA.
As
a result of the foregoing the Company initially recorded goodwill of $1,349,457. The Company conducted a valuation study on the acquisition
of BTA. The final valuation report determined the amount goodwill to be $740,469 and the remaining $650,000 of the goodwill relates to
amortizable intangibles amortized over a fifteen-year period, or approximately $54,166 per year.
During
the three months ended March 31, 2023 the Company recorded $10,833
in amortization expense.
NOTE
5 – NOTE PAYABLE
On
April 3, 2018, CoinTracking entered into a Loan Agreement (the “Loan Agreement”) with CoinTracking GmbH, which provided for
total borrowings of up to $3,000,000. During 2018, CoinTracking borrowed $1,500,000 in exchange for three promissory notes (collectively,
the “CoinTracking Note”) in the principal amounts of $300,000, $700,000, and $500,000, respectively. On December 31, 2018,
the CoinTracking Note was still outstanding. On January 2, 2019, the Company sold its equity ownership stake in CoinTracking GmbH, and
$1,200,000 of the sales proceeds were applied toward repayment of the $1,500,000 outstanding loan amount under the CoinTracking Note.
The remaining balance of $300,000 is outstanding as of September 30, 2022, with a due date of March 31, 2023 which due date was extended
from the prior due date of March 31, 2021 pursuant to an amendment dated December 28, 2018. The CoinTracking Note bears interest at 3%,
which is payable monthly, in arrears. All payments shall be applied first to all accrued and unpaid interest and second to the outstanding
principal balance, as applicable. The maturity date of the CoinTracking Note has not been extended nor has any default been asserted by the lender.
Interest
expense for Notes Payable was $189,816
for the three-month period ended March 31, 2023, compared to $223,965,
during the same three-month period ended March 31, 2022, respectively.
|
● |
On
June 10, 2020, the Company received a loan from the Small Business Administration of $14,100 (the “2020 SBA Loan”). The
2020 SBA Loan bears interest at 3.75% per annum and is payable over 30 years with all payments of principal and interest deferred
for the first 12 months. |
|
● |
On
February 24, 2022, the Company borrowed funds pursuant to the terms of a Securities Purchase Agreement (the “Feb. SPA”)
entered into with AJB, and issued a Promissory Note in the principal amount of $300,000
(the “Feb. Note”) to ABJ in a private transaction for a purchase price of $275,000
(giving effect to an original issue discount). The Feb. Note had a maturity date of August 24, 2022, but it may be
extended for six months upon the consent of AJB and the Company. The Feb. Note bears interest at 10%
per year, and principal and accrued interest is due on the maturity date. The Company may prepay the Feb. Note at any time without
penalty. The Company’s failure to make required payments under the AJB Note or to comply with various covenants, among other
matters, would constitute an event of default. Upon
an event of default under the Feb. SPA or Feb. Note, the Feb. Note will bear interest at 18%, AJB may immediately accelerate the
Feb. Note due date, AJB may convert the amount outstanding under the Feb. Note into shares of Company common stock at a discount to
the market price of the stock, and AJB will be entitled to its costs of collection, among other penalties and
remedies. |
|
|
|
|
● |
On
April 7, 2022, the Company borrowed funds pursuant to the terms of a Securities Purchase Agreement (the “April SPA”)
entered into with Efrat Investments LLC (“Efrat”) and issued a Promissory Note in the principal amount of $220,000 to
Efrat (the “Efrat Note”) in a private transaction for a purchase price of $198,000 (giving effect to an original issue
discount). |
The
Efrat Note had a maturity date of September 7, 2022, although the maturity date may be extended for six months
upon the consent of Efrat and the Company. The Efrat Note bears interest at 10%
per year, and principal and accrued interest is due on the maturity date. The Company may prepay the Efrat Note at any time without
penalty. Any failure by the Company to make required payments under the Efrat Note or to comply with various covenants, among other
matters, would constitute an event of default. Upon
an event of default under the April SPA or the Efrat Note, the Efrat Note will bear interest at 18%, Efrat may immediately
accelerate the Efrat Note due date, Efrat may convert the amount outstanding under the Efrat Note into shares of Company common
stock at a discount to the market price of the stock, and Efrat will be entitled to its costs of collection, among other penalties
and remedies.
|
● |
On
May 3, 2022, the Company borrowed funds pursuant to the terms of a Securities Purchase Agreement (the “May AJB SPA”)
entered into with AJB, and issued a Promissory Note in the principal amount of $1,000,000 (the “May AJB Note”) to AJB
in a private transaction for a purchase price of $900,000 (giving effect to a 10% original issue discount). In connection with the
sale of the AJB Note, the Company also paid certain fees and due diligence costs of AJB and brokerage fees. |
At
the closing the Company repaid all obligations owed to AJB pursuant to a 10% promissory note in the principal amount of $750,000 issued
in favor of AJB in January 2022 as generally described above. After the repayment of that promissory note, and after payment of the fees
and costs, the $138,125 net proceeds from the issuance of the May AJB Note was utilized for working capital and other general corporate
purposes.
The
May AJB Note had a maturity date of November 3, 2022, but it may be extended by the Company for six months with
the interest rate to increase during the extension period. The Company has extended the maturity date of the May AJB Note. The May
AJB Note bears interest at 10% per year, and principal and accrued interest is due on the maturity date. The Company may prepay the
May AJB Note at any time without penalty. Under the terms of the May AJB Note, the Company may not sell a significant portion of its
assets without the approval of AJB, may not issue additional debt that is not subordinate to AJB, must comply with the
Company’s reporting requirements under the Securities Exchange Act of 1934, and must maintain the listing of the
Company’s common stock on the OTC Market or other exchange, among other restrictions and requirements. The Company’s
failure to make required payments under the May AJB Note or to comply with any of these covenants, among other matters, would
constitute an event of default. Upon
an event of default under the May AJB SPA or May AJB Note, the May AJB Note will bear interest at 18%, AJB may immediately
accelerate the May AJB Note due date, AJB may convert the amount outstanding under the May AJB Note into shares of Company common
stock at a discount to the market price of the stock, and AJB will be entitled to its costs of collection, among other penalties and
remedies.
|
● |
On
July 8, 2022, the Company borrowed funds pursuant to a Securities Purchase Agreement (the “Diagonal SPA”) entered into
with 1800 Diagonal Lending, LLC (“Diagonal”), and Diagonal purchased a convertible promissory note (the “July Note”)
from the Company in the aggregate principal amount of $79,250. Pursuant to the Diagonal SPA, the Company agreed to reimburse Diagonal
for certain fees in connection with entry into the diagonal SPA and the issuance of the Note. |
The
maturity date of the Note is July 5, 2023 (the “Maturity Date”). The July Note bears interest at a rate of 10% per annum,
and a default interest of 22% per annum. Diagonal has the option to convert all of the outstanding amounts due under the July Note into
shares of the Company’s common stock beginning on the date which is 180 days following the date of the Note and ending on the later
of: (i) the Maturity Date and (ii) the date of payment of the default amount, as such term is defined under the July Note. The conversion
price under the July Note for each share of common stock is equal to 65% of the lowest trading price of the Company’s common stock
for the 10 trading days prior to the conversion date. The conversion of the July Note is subject to a beneficial ownership limitation
of 4.99% of the number of shares of common stock outstanding immediately after giving effect to such conversion. Failure of the Company
to convert the July Note and deliver the common stock when due will result in the Company paying Diagonal a monetary penalty for each
day beyond such deadline.
Prior
to the 180th day of the issuance date July Note, the Company may prepay the July Note in whole or in part, however, if it does so between
the issuance date and the date which is 60 days from the issuance date, the repayment percentage is 115%. If the Company prepays the
July Note between the 61st day after issuance and the 120th day after issuance, the prepayment percentage is 120%. If the Company prepays
the July Note between the 121st day after issuance and 180 days after issuance, the prepayment percentage is 125%. After such time, the
Company can submit an optional prepayment notice to Diagonal, however the prepayment shall be subject to the agreement between the Company
and Diagonal on the applicable prepayment percentage.
|
● |
On
July 27, 2022, The Company entered into a Securities Purchase Agreement (the “Purchase Agreement”) with Coventry Enterprises,
LLC (“Coventry”), pursuant to which Coventry purchased a 10% unsecured promissory Note (the “Coventry Note”)
from the Company in the principal amount of $200,000, of which $40,000 was retained by Coventry through an “Original Issue
Discount” for due diligence and origination related to the transaction. Pursuant to the terms of the Purchase Agreement, the
Company also agreed to issue 25,000 shares of restricted common stock to Coventry as additional consideration for the purchase of
the Coventry Note. In addition, in the Purchase Agreement the Company granted Coventry a right of first refusal with respect to certain
types of equity financing transactions the Company may pursue or effect. |
The
Coventry Note bears interest at a rate of 10% per annum, with guaranteed interest (the “Guaranteed Interest”) of $20,000
being deemed earned as of date of issuance of the Coventry Note. The Coventry Note matures on July 15, 2023. The principal amount and
the Guaranteed Interest is due and payable in seven equal monthly payments of $31,428.57, beginning on December 15, 2022 and continuing
on the third day of each month thereafter until paid in full.
Any
or all of the principal amount and the Guaranteed Interest may be prepaid at any time and from time to time, in each case without penalty
or premium.
If
an Event of Default (as defined in the Coventry Note) occurs, consistent with the terms of the Coventry Note, the Coventry Note will
become convertible, in whole or in part, into shares of the Company’s common stock at Coventry’s option, subject to a 4.99%
beneficial ownership limitation (which may be increased up to 9.99% by Coventry). The per share conversion price is 90% of the lowest
volume-weighted average trading price during the 20-trading day period before conversion.
In
addition to certain other remedies, if an Event of Default occurs, consistent with the terms of the Coventry Note, the Coventry Note
will bear interest on the aggregate unpaid principal amount and Guaranteed Interest at the rate of the lesser of 18% per annum or the
maximum rate permitted by law.
On April 24, 2023, the Company received a letter (the “Notice of Conversion”) from Coventry formally
notifying the Company of an event of default under Section 7(a)(i) of the Coventry Note. The Company was in violation of covenants in
the Note that require the Company make the payment of any principal amount, guaranteed interest, or any other interest due under the Coventry
Note, when due, subject to a five day cure period. Upon an event of default, consistent with the terms of the Coventry Note, the Coventry
Note becomes convertible, in whole or in part, into shares of the Company’s Common Stock at Coventry’s option. As set forth
in the Notice of Conversion, Coventry elected to convert $17,916.94 of principal and $2,083.06 of interest under the Note into Conversion
Shares of the Company.
●
On September 30, 2022, the Company borrowed funds pursuant to a Securities Purchase Agreement (the “SPA”) entered into with
1800 Diagonal Lending, LLC (“Diagonal”), and Diagonal purchased a convertible promissory note (the “Note”) from
the Company in the aggregate principal amount of $108,936 (giving effect to an original issue discount). The SPA contains customary representations
and warranties by the Company and Diagonal typically contained in such documents.
A
portion of the proceeds from the sale of the Note were used by the parties to satisfy all remaining amounts due under a convertible promissory
note dated January 11, 2022, issued by the Company to Sixth Street Lending, LLC. After payment of fees, and after satisfaction of the
January 11, 2022 convertible promissory note in favor of Sixth Street Lending, the net proceeds to the Company were $80,000, which will
be used for working capital and other general corporate purposes.
The
Note has a maturity date of September 26, 2023, and the Company has agreed to pay interest on the unpaid principal balance of the
Note at the rate of twelve percent (12.0%) per annum from the date on which the Note was issued until the same becomes due and
payable, whether at maturity or upon acceleration or by prepayment or otherwise. Payments are due monthly, beginning on November 15,
2022. The Company has the right to prepay the Note in accordance with the terms set forth in the Note.
Following
an event of default, and subject to certain limitations, the outstanding amount of the Note may be converted into shares of Company common
stock.
Amounts
due under the Note would be converted into shares of the Company’s common stock at a conversion price equal to 75% of the lowest
trading price with a 10-day lookback immediately preceding the date of conversion. In no event may the lender effect a conversion if
such conversion, along with all other shares of Company common stock beneficially owned by the lender and its affiliates would exceed
4.99% of the outstanding shares of Company common stock. In addition, upon the occurrence and during the continuation of an event of
default the Note will become immediately due and payable and the Company shall pay to the lender, in full satisfaction of its obligations
thereunder, additional amounts as set forth in the Note.
On May 8, 2023, the Company received a letter (the “Notice of Conversion”) from Diagonal formally notifying
the Company of an event of default under Article III of the Note. The Company is in violation of covenants in the Note that require the
Company make the payment of any principal or interest due under the Note, when due, subject to a ten day cure period. Upon an event of
default, consistent with the terms of the Note, the Note becomes convertible, in whole or in part, into shares of the Company’s
Common Stock at Diagonal’s option. As set forth in the Notice of Conversion, Diagonal elected to convert $15,000 of principal under
the Note into Conversion Shares of the Company.
●
On December 15, 2022, the Company borrowed funds pursuant to a Securities Purchase Agreement (the “SPA”) entered into with
1800 Diagonal Lending, LLC (“Diagonal”), and Diagonal purchased a convertible promissory note (the “Note”) from
the Company in the aggregate principal amount of $88,760 (giving effect to an original issue discount). Net proceeds from the sale of
the Note will be used primarily for general working capital purposes. The SPA contains customary representations and warranties by the
Company and Diagonal typically contained in such documents.
The
Note has a maturity date of December 9, 2023, and the Company has agreed to pay interest on the unpaid principal balance of the Note
at the rate of twelve percent (12.0%) per annum, with interest being payable through a one-time interest charge of $10,651 being applied
on the principal amount of the Note on the issuance date. Payments are due monthly, beginning on January 30, 2023. The Company has the
right to prepay the Note in accordance with the terms set forth in the Note.
Following
an event of default, and subject to certain limitations, the outstanding amount of the Note may be converted into shares of Company common
stock. Amounts due under the Note would be converted into shares of the Company’s common stock at a conversion price equal to 75%
of the lowest trading price with a 10-day lookback immediately preceding the date of conversion. In no event may the lender effect a
conversion if such conversion, along with all other shares of Company common stock beneficially owned by the lender and its affiliates
would exceed 4.99% of the outstanding shares of Company common stock. In addition, upon the occurrence and during the continuation of
an event of default the Note will become immediately due and payable and the Company shall pay to the lender, in full satisfaction of
its obligations thereunder, additional amounts as set forth in the Note.
●
On December 29, 2022, the Company entered into a First Amendment to Promissory Note (the “Amendment”) to amend certain terms
of a the Note originally issued by the Company on or about May 3, 2022 in favor of AJB Capital Investments, LLC (“AJB”).
Pursuant to the Amendment, AJB loaned the Company an additional $125,000 (resulting in proceeds to the Company of $100,000 after giving
effect to an original issue discount of $25,000), and, as a result the Amendment served to increase the face amount of the Note to $1,125,000
to give effect to the additional funds loaned to the Company. All transaction documents originally entered into by the parties in connection
with the issuance of the Note were amended to cause the term “Principal” to mean the sum of $1,125,000. Except as amended
by the Amendment all of the original terms and conditions of the Note remain as set forth in the original transaction documents.
The
Company used proceeds of the additional loan amount, in part, to satisfy in full all remaining obligations owed by the Company pursuant
to a promissory note in the principal amount of $79,250 issued in favor of 1800 Diagonal Lending, LLC in July 2022 (the “July Diagonal
Note”). As a result, the July Diagonal Note is satisfied in full and was terminated.
●
On January 10, 2023, the Company borrowed funds pursuant to a Securities Purchase Agreement (the “SPA”) entered into with
1800 Diagonal Lending, LLC (“Diagonal”), and Diagonal purchased a convertible promissory note (the “Note”) from
the Company in the aggregate principal amount of $79,250. Pursuant to the SPA, the Company agreed to reimburse Diagonal for certain fees
in connection with entry into the SPA and the issuance of the Note. The SPA contains customary representations and warranties by the
Company and Diagonal typically contained in such documents.
The
maturity date of the Note is January 3, 2024 (the “Maturity Date”). The Note bears interest at a rate of 10% per annum, and
a default interest of 22% per annum. Diagonal has the option to convert all of the outstanding amounts due under the Note into shares
of the Company’s common stock beginning on the date which is 180 days following the date of the Note and ending on the later of:
(i) the Maturity Date and (ii) the date of payment of the default amount, as such term is defined under the Note. The conversion price
under the Note for each share of common stock is equal to 65% of the lowest trading price of the Company’s common stock for the
10 trading days prior to the conversion date. The conversion of the Note is subject to a beneficial ownership limitation of 4.99% of
the number of shares of common stock outstanding immediately after giving effect to such conversion. Failure of the Company to convert
the Note and deliver the common stock when due will result in the Company paying Diagonal a monetary penalty for each day beyond such
deadline.
The
Company may prepay the Note in whole, however, if it does so between the issuance date and the date which is 60 days from the issuance
date, the repayment percentage is 115%. If the Company prepays the Note on or between the 61st day after issuance and the 90th day after
issuance, the prepayment percentage is 120%. If the Company prepays the Note on or between the 91st day after issuance and 180 days after
issuance, the prepayment percentage is 125%. After such time, the Company can submit an optional prepayment notice to Diagonal, however
the prepayment shall be subject to the agreement between the Company and Diagonal on the applicable prepayment percentage.
Pursuant
to the Note, as long as the Company has any obligations under the Note, the Company cannot without Diagonal’s written consent,
sell, lease or otherwise dispose of any significant portion of its assets which would render the Company a “shell company”
as such term is defined in SEC Rule 144. Additionally, under the Note, any consent to the disposition of any assets may be conditioned
on a specified use of the proceeds of disposition.
The
Note contains standard and customary events of default such as failing to timely make payments under the Note when due, the failure of
the Company to timely comply with the Securities Exchange Act of 1934, as amended, reporting requirements and the failure to maintain
a listing on the OTC Markets. The occurrence of any of the events of default, entitle Diagonal, among other things, to accelerate the
due date of the unpaid principal amount of, and all accrued and unpaid interest on, the Note. Upon an “Event of Default”,
interest shall accrue at a default interest rate of 22%, and the Company may be obligated pay to the Diagonal an amount equal to 150%
of all amounts due and owing under the Note.
●
On February 2, 2023, the Company borrowed funds pursuant to a Securities Purchase Agreement (the “SPA”) entered into with
Fast Capital, LLC (“Fast Capital”), and Fast Capital purchased a 10% convertible promissory note (the “Note”)
from the Company in the aggregate principal amount of $115,000. The Note has an original issue discount of $10,000, resulting in gross
proceeds to the Company of $105,000. Pursuant to the SPA, the Company agreed to reimburse Fast Capital for certain fees in connection
with entry into the SPA and the issuance of the Note. The SPA contains certain covenants and customary representations and warranties
by the Company and Fast Capital typically contained in such documents.
The
maturity date of the Note is January 30, 2024. The Note bears interest at a rate of 10% per annum, and a default interest of 24% per
annum. Interest is payable in shares of Company common stock.
For
the first six months, the Company has the right to prepay principal and accrued interest due under the Note at a premium of between 15%
and 40% depending on when it is repaid. The Note may not be prepaid after the 180th day of its issuance.
Fast
Capital has the right at any time after the six-month anniversary of the date of issuance of the Note to convert all or any part of the
outstanding and unpaid principal amount of the Note into Company common stock, subject to a beneficial ownership limitation. The conversion
price of the Note equals 60% of the lowest closing price of the Company’s common stock for the 20 prior trading days, including
the day upon which a notice of conversion is delivered.
The
Note contains various covenants standard and customary events of default such as failing to timely make payments under the Note when
due, the failure to maintain a listing on the OTC Markets or the Company defaulting on any other note or similar debt obligation into
which the Company has entered and failed to cure within the applicable grace period. The occurrence of any of the events of default,
entitle First Capital, among other things, to accelerate the due date of the unpaid principal amount of, and all accrued and unpaid interest
on, the Note. Upon an “Event of Default”, interest shall accrue at a default interest rate of 24%, and certain defined events
of default may give rise to other remedies (such as, if the Company is delinquent in its periodic report filings with the Securities
and Exchange Commission then the conversion price of the Note may be decreased).
●
On March 7, 2023, the Company borrowed funds pursuant to a Securities Purchase Agreement (the “SPA”) entered into with 1800
Diagonal Lending, LLC (“Diagonal”), and Diagonal purchased a convertible promissory note (the “Note”) from the
Company in the aggregate principal amount of $54,250. Pursuant to the SPA, the Company agreed to reimburse Diagonal for certain fees
in connection with entry into the SPA and the issuance of the Note. The SPA contains customary representations and warranties by the
Company and Diagonal typically contained in such documents.
The
maturity date of the Note is March 2, 2024 (the “Maturity Date”). The Note bears interest at a rate of 10% per annum, and
a default interest of 22% per annum. Diagonal has the option to convert all of the outstanding amounts due under the Note into shares
of the Company’s common stock beginning on the date which is 180 days following the date of the Note and ending on the later of:
(i) the Maturity Date and (ii) the date of payment of the default amount, as such term is defined under the Note. The conversion price
under the Note for each share of common stock is equal to 65% of the lowest trading price of the Company’s common stock for the
10 trading days prior to the conversion date. The conversion of the Note is subject to a beneficial ownership limitation of 4.99% of
the number of shares of common stock outstanding immediately after giving effect to such conversion. Failure of the Company to convert
the Note and deliver the common stock when due will result in the Company paying Diagonal a monetary penalty for each day beyond such
deadline.
The
Company may prepay the Note in whole, however, if it does so between the issuance date and the date which is 60 days from the issuance
date, the repayment percentage is 115%. If the Company prepays the Note on or between the 61st day after issuance and the 90th day after
issuance, the prepayment percentage is 120%. If the Company prepays the Note on or between the 91st day after issuance and 180 days after
issuance, the prepayment percentage is 125%. After such time, the Company can submit an optional prepayment notice to Diagonal, however
the prepayment shall be subject to the agreement between the Company and Diagonal on the applicable prepayment percentage.
Pursuant
to the Note, as long as the Company has any obligations under the Note, the Company cannot without Diagonal’s written consent,
sell, lease or otherwise dispose of any significant portion of its assets.
The
Note contains standard and customary events of default such as failing to timely make payments under the Note when due, the failure of
the Company to timely comply with the Securities Exchange Act of 1934, as amended, reporting requirements and the failure to maintain
a listing on the OTC Markets. The occurrence of any of the events of default, entitle Diagonal, among other things, to accelerate the
due date of the unpaid principal amount of, and all accrued and unpaid interest on, the Note. Upon an “Event of Default”,
interest shall accrue at a default interest rate of 22%, and the Company may be obligated pay to the Diagonal an amount equal to 150%
of all amounts due and owing under the Note.
NOTE
6 – CONVERTIBLE NOTES
The
balance of outstanding Convertible Notes was $125,000
as of March 31, 2023 and December 31, 2022.
In
June 2020, the Company issued Convertible Notes (“June 2020 Notes”) to an accredited investor for an aggregate amount of
$5,000. The June 2020 Notes mature in June 2025, unless earlier converted. The June 2020 Notes bear interest at a rate of 5% per year.
The June 2020 Notes will automatically convert into shares of common stock on the earlier to occur of a) a qualified equity financing,
with the conversion price equal to 50% of the common stock price paid by the purchasers of the equity, or b) on the maturity date, at
a price per share equal to the fair market value of the Company’s common stock on that date. If a change in control occurs before
either of the automatic conversion events, the holders of the June 2020 Notes will have the option to convert the June 2020 Notes at
a price per share equal to the fair market value of the common stock at the time of such conversion. The Company can prepay the principal
and interest, in cash, at any time without any premium or penalty. The June 2020 Notes have no voting rights, do not participate in dividends,
and are unsecured. The Company believes it is more likely than not that the June 2020 Notes will not be automatically converted in connection
with a qualified equity financing prior to either prepayment or automatic conversion on maturity.
In
April 2020, the Company issued three Convertible Notes (“April 2020 Notes”) to three accredited investors for an aggregate
amount of $22,500. The April 2020 Notes mature in April 2025, unless earlier converted. The April 2020 Notes bear interest at a rate
of 5% per year. The April 2020 Notes will automatically convert into shares of common stock on the earlier to occur of a) a qualified
equity financing, with the conversion price equal to 50% of the common stock price paid by the purchasers of the equity, or b) on the
maturity date, at a price per share equal to the fair market value of the Company’s common stock on that date. If a change in control
occurs before either of the automatic conversion events, the holders of the April 2020 Notes will have the option to convert the April
2020 Notes at a price per share equal to the fair market value of the common stock at the time of such conversion. The Company can prepay
the principal and interest, in cash, at any time without any premium or penalty. The April 2020 Notes have no voting rights, do not participate
in dividends, and are unsecured. The Company believes it is more likely than not that the April 2020 Notes will not be automatically
converted in connection with a qualified equity financing prior to either prepayment or automatic conversion on maturity.
In
February 2020, the Company issued three Convertible Notes (“February 2020 Notes”) to three accredited investors for an aggregate
amount of $22,500. The February 2020 Notes mature in February 2025, unless earlier converted. The February 2020 Notes bear interest at
a rate of 5% per year. The February 2020 Notes will automatically convert into shares of common stock on the earlier to occur of a) a
qualified equity financing, with the conversion price equal to 50% of the common stock price paid by the purchasers of the equity, or
b) on the maturity date, at a price per share equal to the fair market value of the Company’s common stock on that date. If a change
in control occurs before either of the automatic conversion events, the holders of the February 2020 Notes will have the option to convert
the February 2020 Notes at a price per share equal to the fair market value of the common stock at the time of such conversion. The Company
can prepay the principal and interest, in cash, at any time without any premium or penalty. The February 2020 Notes have no voting rights,
do not participate in dividends, and are unsecured. The Company believes it is more likely than not that the February 2020 Notes will
not be automatically converted in connection with a qualified equity financing prior to either prepayment or automatic conversion on
maturity.
Interest
expense for Convertible Notes was $1,541
for the three months ended March 31, 2023, and March 31, 2022, respectively.
NOTE
7 – WARRANTS FOR COMMON STOCK
As
of March 31, 2023, outstanding warrants to purchase shares of the Company’s common stock were as follows:
SCHEDULE OF OUTSTANDING WARRANTS TO PURCHASE SHARES OF COMMON STOCK
Issuance Date | |
Exercisable for | |
Expiration Date | |
Exercise Price | | |
Number of Shares
Outstanding Under Warrants | |
September 2019 | |
Common Shares | |
September 24, 2022 | |
$ | 0.01 | | |
| 75,000 | |
February 2020 | |
Common Shares | |
February 6, 2030 | |
$ | 0.01 | | |
| 10,000 | |
February 2020 | |
Common Shares | |
February 12, 2030 | |
$ | 0.01 | | |
| 2,500 | |
February 2020 | |
Common Shares | |
February 19, 2030 | |
$ | 0.01 | | |
| 10,000 | |
April 2020 | |
Common Shares | |
April 20, 2030 | |
$ | 0.01 | | |
| 22,500 | |
June 2020 | |
Common Shares | |
June 9, 2030 | |
$ | 0.01 | | |
| 5,000 | |
March 2021 | |
Common Shares | |
February 28, 2026 | |
$ | 0.50 | | |
| 362,500 | |
January 2022 | |
Common Shares | |
January 12, 2025 | |
$ | 5.25 | | |
| 500,000 | |
February 2022 | |
Common Shares | |
February 24, 2025 | |
$ | 5.25 | | |
| 200,000 | |
April 2022 | |
Common Shares | |
April 7, 2025 | |
$ | 5.25 | | |
| 146,667 | |
May 2022 | |
Common Stock | |
May 3, 2025 | |
$ | 5.25 | | |
| 750,000 | |
March 2023 | |
Common Stock | |
March 8, 2028 | |
$ | 0.00001 | | |
| 474,780 | |
March 2023 | |
Common Stock | |
March 13, 2028 | |
$ | 0.00001 | | |
| 7,000,000 | |
The
exercise price of the warrants is subject to adjustment from time to time, as provided therein, to prevent dilution of purchase rights
granted thereunder. The warrants are considered indexed to the Company’s own stock and therefore no subsequent remeasurement is
required.
NOTE
8 - SUMMARY OF STOCK OPTIONS
On
July 21, 2017, the Company’s board of directors adopted The Crypto Company 2017 Equity Incentive Plan (the “Plan”),
which was approved by its stockholders on August 24, 2017. The Plan is administered by the board of directors (the “Administrator”).
Under the Plan, the Company may grant equity awards to eligible participants which may take the form of stock options (both incentive
stock options and non-qualified stock options) and restricted stock awards. Awards may be granted to officers, employees, non-employee
directors (as defined in the Plan) and other key persons (including consultants and prospective employees). The term of any stock option
award may not exceed 10 years and may be subject to vesting conditions, as determined by the Administrator. Options granted generally
vest over eighteen to thirty-six months. Incentive stock options may be granted only to employees of the Company or any subsidiary that
is a “subsidiary corporation” within the meaning of Section 424(f) of the Internal Revenue Code.
During
the three-month period ended March 31, 2023, the Company did not issue any stock options.
5,000,000
shares of the Company’s common stock are reserved for issuance under the Plan. As of March 31, 2023, there are outstanding
stock option awards issued from the Plan covering a total of 2,281,429
shares of the Company’s common stock and there remain reserved for future awards 2,718,571
shares of the Company’s common stock.
SCHEDULE OF STOCK OPTIONS ACTIVITY
| |
Weighted Average | | |
| |
| |
| | |
Weighted | | |
Remaining | | |
| |
| |
| | |
Average | | |
Contractual | | |
Aggregate | |
| |
Number of Shares | | |
Exercise Price | | |
Term (years) | | |
Intrinsic Value | |
Options outstanding, on December 31, 2022 | |
| 2,281,429 | | |
$ | 2.26 | | |
| 3.25 | | |
| 5,155,003 | |
Options granted | |
| - | | |
| - | | |
| - | | |
| - | |
Options canceled | |
| - | | |
| - | | |
| - | | |
| - | |
Options exercised | |
| - | | |
| - | | |
| - | | |
| - | |
Options outstanding, on March 31, 2023 | |
| 2,281,429 | | |
$ | 2.26 | | |
| 3.00 | | |
$ | 5,155,003 | |
Vested and exercisable | |
| 2,281,429 | | |
$ | 2.26 | | |
| 3.00 | | |
$ | 5,155,003 | |
The
Company recognized $-0-
for share-based compensation related to stock options for the three month period ended March 31, 2023. There were no options
exercised for the three months ended March 31, 2023.
The
Company granted 1,665,157
shares of restricted stock during the three-month period ended March 31, 2023 (although such shares were not issued under the
Plan).
The
Company recognized $386,560
for share-based compensation related to restricted stock issued for the three month period ended March 31, 2023. As of March 31,
2023, there was $-0-
of unrecognized compensation costs related to stock options issued to employees and nonemployees, and the stock options had no
intrinsic value since they were all “out of the money” as of March 31, 2023.
NOTE
9- COMMITMENTS AND CONTINGENCIES
Facility
rent expense was $-0- for the three months ended March 31, 2023, and March 31, 2022, respectively.
NOTE
10 – SUBSEQUENT EVENTS
Subsequent to March 31, 2023 the Company issued 6,286,783 common shares
pursuant to the conversion of $162,154 of convertible debt.